Compounds > ljc 10627
Page last updated: 2024-08-25

ljc 10627 and rifampin

ljc 10627 has been researched along with rifampin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Bell, DT; Culhane, JC; Ebner, DC; Heuer, AM; Ippoliti, JT; Kaushik, A; Lamichhane, G; Parrish, N1
Kaushik, A; Lamichhane, G; Makkar, N; Pandey, P; Parrish, N; Singh, U1
Ammerman, NC; Dooley, KE; Dorman, SE; Kaushik, A; Lamichhane, G; Nuermberger, EL; Story-Roller, E; Tasneen, R1

Other Studies

5 other study(ies) available for ljc 10627 and rifampin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
An evolved oxazolidinone with selective potency against Mycobacterium tuberculosis and gram positive bacteria.
    Bioorganic & medicinal chemistry letters, 2016, 08-01, Volume: 26, Issue:15

    Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Structure-Activity Relationship

2016
Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10

    Topics: Antitubercular Agents; beta-Lactams; Carbapenems; Doripenem; Drug Synergism; Meropenem; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium tuberculosis; Rifampin; Thienamycins

2015
In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    The Journal of antimicrobial chemotherapy, 2017, 08-01, Volume: 72, Issue:8

    Topics: Animals; Antibiotics, Antitubercular; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; Female; Mice, Inbred BALB C; Microbial Viability; Mycobacterium tuberculosis; Rifampin; Thienamycins; Treatment Outcome; Tuberculosis

2017